Search results
Cantor Fitzgerald Reiterates Overweight Rating for Annexon (NASDAQ:ANNX)
ETF DAILY NEWS· 4 days agoAnnexon (NASDAQ:ANNX – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Cantor Fitzgerald in a research note ...
Decoding Novo Nordisk's Options Activity: What's the Big Picture? - Novo Nordisk (NYSE:NVO)
Benzinga· 8 hours agoAn analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160. An analyst from Cantor Fitzgerald ...
Cantor Fitzgerald Reaffirms “Neutral” Rating for Teradyne (NASDAQ:TER)
ETF DAILY NEWS· 2 days agoCantor Fitzgerald restated their neutral rating on shares of Teradyne (NASDAQ:TER – Free Report) in a research note published on Thursday, Benzinga reports ...
Lutnick Lands Wall Street Giants for His Futures Fight With CME
Bloomberg· 5 days agoHave a confidential tip for our reporters? Howard Lutnick is lining up some of Wall Street’s biggest...
Lutnick Lands Wall Street Giants for His Futures Fight With CME
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Howard Lutnick is lining up some of Wall Street’s biggest power players for a fresh...
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends - Incyte...
Benzinga· 6 days agoIncyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald...
Investing in Archer Aviation Inc
Knox Daily· 8 hours agoPercent R suggests that price movement has been low at 43.84%. Stochastics %K at 49.15% indicates the stock is a holding. The most recent change occurred on November 30, 2021 when Cantor ...
VinFast Auto Ltd. (NASDAQ:VFS) Expected to Post FY2024 Earnings of ($0.91) Per Share
ETF DAILY NEWS· 6 days agoVinFast Auto Ltd. (NASDAQ:VFS – Free Report) – Stock analysts atCantor Fitzgerald lowered their...
Analyzing Checkpoint Therapeutics Inc
Knox Daily· 2 hours agoA number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Cantor < ...
Cantor Fitzgerald Equities Analysts Increase Earnings Estimates for Regeneron Pharmaceuticals, Inc....
ETF DAILY NEWS· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for Regeneron Pharmaceuticals ...
